Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Helissey

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|April 10, 2021
[Why and how to assess older people with cancer?]Carole Helissey, Romain Geiss, Capucine Baldini, et al.
Cancer Reports (Hoboken, N.J.)|December 9, 2022
Prognostic factors of toxicity of immune checkpoint inhibitors in nonsmall cell lung cancer and small cell lung cancer patients: The ToxImmune studyFrancoise Difoum, Antoine Schernberg, Hélène Vanquaethem, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
[18F]FDG PET/CT Integration in Evaluating Immunotherapy for Lung Cancer: A Clinician's Practical ApproachJuliette Brezun, Nicolas Aide, Evelyne Peroux, et al.
Discovery Medicine|June 30, 2011
External beam radiotherapy in the management of spinal metastases: review of current strategies and perspectives for highly conformal irradiation modalitiesCarole Helissey, Antonin Levy, Julian Jacob, et al.
Therapeutic Advances in Medical Oncology|September 16, 2025
Prevention and management of PARP inhibitor-related haematological toxicities in prostate cancer: French expert opinion using the Delphi methodOphélie Cassuto, Romain Mathieu, Carole Helissey, et al.
Bulletin Du Cancer|July 9, 2026
[How to prevent and manage PARP inhibitor-related hematological toxicities in prostate cancer?]Ophélie Cassuto, Antonin Schmitt, Carole Helissey, et al.
Frontiers in Pharmacology|June 11, 2021
COVID-19-Associated Pneumonia: Radiobiological InsightsSabine François, Carole Helissey, Sophie Cavallero, et al.
Annales De Biologie Clinique|February 2, 2012
[Primary granulocytic sarcoma of the peritoneum: a case report and literature review]Hicham Eddou, Abderrahmane El Bouzidi, Elodie Valero, et al.
Cell Cycle (Georgetown, Tex.)|January 31, 2016
Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistanceTony Sourisseau, Carole Helissey, Céline Lefebvre, et al.
International Journal of Cancer|June 30, 2022
Effectiveness of a digital telemonitoring platform for cancer care of older patients: The ConnectElderlyPatientToDoctor studyClémentine Rivière, Laurent Brureau, Charles Parnot, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|April 10, 2021
[Why and how to assess older people with cancer?]Carole Helissey, Romain Geiss, Capucine Baldini, et al.
Cancer Reports (Hoboken, N.J.)|December 9, 2022
Prognostic factors of toxicity of immune checkpoint inhibitors in nonsmall cell lung cancer and small cell lung cancer patients: The ToxImmune studyFrancoise Difoum, Antoine Schernberg, Hélène Vanquaethem, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
[18F]FDG PET/CT Integration in Evaluating Immunotherapy for Lung Cancer: A Clinician's Practical ApproachJuliette Brezun, Nicolas Aide, Evelyne Peroux, et al.
Discovery Medicine|June 30, 2011
External beam radiotherapy in the management of spinal metastases: review of current strategies and perspectives for highly conformal irradiation modalitiesCarole Helissey, Antonin Levy, Julian Jacob, et al.
Therapeutic Advances in Medical Oncology|September 16, 2025
Prevention and management of PARP inhibitor-related haematological toxicities in prostate cancer: French expert opinion using the Delphi methodOphélie Cassuto, Romain Mathieu, Carole Helissey, et al.
Bulletin Du Cancer|July 9, 2026
[How to prevent and manage PARP inhibitor-related hematological toxicities in prostate cancer?]Ophélie Cassuto, Antonin Schmitt, Carole Helissey, et al.
Frontiers in Pharmacology|June 11, 2021
COVID-19-Associated Pneumonia: Radiobiological InsightsSabine François, Carole Helissey, Sophie Cavallero, et al.
Annales De Biologie Clinique|February 2, 2012
[Primary granulocytic sarcoma of the peritoneum: a case report and literature review]Hicham Eddou, Abderrahmane El Bouzidi, Elodie Valero, et al.
Cell Cycle (Georgetown, Tex.)|January 31, 2016
Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistanceTony Sourisseau, Carole Helissey, Céline Lefebvre, et al.
International Journal of Cancer|June 30, 2022
Effectiveness of a digital telemonitoring platform for cancer care of older patients: The ConnectElderlyPatientToDoctor studyClémentine Rivière, Laurent Brureau, Charles Parnot, et al.
Pageof 6